Back to Agenda
Session 3A: Next Generation Therapeutics (mRNA, Gene Editing, Cell Therapy)
Session Chair(s)
Julian Beach, MBA
Interim Executive Director, Healthcare Quality and Access, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Are Innovative Products Actually Reaching the Patients Who Need Them Most?
Have an account?